Does INFLIXIMAB Cause Exposure to sars-cov-2? 201 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 201 reports of Exposure to sars-cov-2 have been filed in association with INFLIXIMAB (Renflexis). This represents 0.1% of all adverse event reports for INFLIXIMAB.
201
Reports of Exposure to sars-cov-2 with INFLIXIMAB
0.1%
of all INFLIXIMAB reports
0
Deaths
52
Hospitalizations
How Dangerous Is Exposure to sars-cov-2 From INFLIXIMAB?
Of the 201 reports, 52 (25.9%) required hospitalization.
Is Exposure to sars-cov-2 Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 201 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Exposure to sars-cov-2?
ADALIMUMAB (182)
INFLIXIMAB-DYYB (143)
CERTOLIZUMAB PEGOL (89)
DUPILUMAB (78)
TOFACITINIB (66)
RITUXIMAB (49)
ETEPLIRSEN (36)
PREDNISONE (35)
ETANERCEPT (33)
SECUKINUMAB (33)
Which INFLIXIMAB Alternatives Have Lower Exposure to sars-cov-2 Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT